Source: MSD |

The Foundation of Merck & Co., Inc., Kenilworth, NJ, USA Announces Grant to American Cancer Society to Improve Access to Cancer Care in Resource-Limited Settings

$1.99 Million Grant Supports Patient Navigation Initiative in East Africa

The Foundation of Merck & Co., Inc., Kenilworth, NJ, USA (the Foundation) and the American Cancer Society (ACS) announced today that the Foundation awarded a $1.99 million, five-year grant to ACS to improve support and access to care for people living with cancer in low-and-middle-income countries, particularly in East Africa. This…

Source: MSD |

MSD joins call to action on vaccination in Africa, celebrates Vaccine Heroes

More than 500 million children under the age of 5 years die from vaccine-preventable diseases in Africa each year

MSD (http://www.MSD.com), known as Merck in the United States and Canada, has joined calls for more action to ensure a larger number of people across Africa are vaccinated against life-threatening diseases. As the continent marks African Vaccination Week, the annual World Health Organisation (WHO) initiative to promote the use of…

Source: MSD |

Ask your questions LIVE to health experts from South Africa as the world marks the end of ‘African Vaccination Week’ 2019

MSD, commonly known as Merck in United States and Canada, will host an online press conference on the last day of the ‘African Vaccination Week’ 2019, to raise awareness on vaccine preventable life-threatening diseases and the need for their prevention across Africa

Journalists interested in attending this event will be able to ask questions live via Internet. Speakers: Lizeth Kruger, Specialized Primary Health Care Nurse Practitioner and Dr Doreen Sindisiwe van Zyl, General health Practitioner (GP), in Kempton Park, South Africa Date: Tuesday April 30, 2019 Time: From 10:00am South African Time…

MSD
Source: MSD |

This is a historic moment for the government and people of Ethiopia…

The launch of the National Immunisation Programme (NIP) in Ethiopia is an important step towards achieving the vision of a world where the number of women and men affected by certain HPV-related cancers is greatly reduced

MSD (www.MSD.co.za) congratulates Ethiopia on the successful launch of the National Immunisation Programme (NIP) for the Human-Papillomavirus (HPV - the main cause of cervical cancer).[1] Each year an estimated 7 095 Ethiopian women are diagnosed with cervical cancer. In 2012 the mortality rate related to cervical cancer for Ethiopian women…

MSD
Source: MSD |

MSD Congratulates Senegal on the Successful Launch of its National Immunisation Programme for Human-Papillomavirus (HPV)

MSD is committed to working with the government of Senegal and other partners on the continent to ensure that this goal becomes a reality

MSD (www.MSD.co.za), known as Merck & Co., Inc., (NYSE: MRK) in the United States and Canada, congratulates Senegal on the successful launch of the National Immunisation Programme (NIP) for the Human-Papillomavirus (HPV - the main cause of cervical cancer).[1] Approximately 530 000 women are diagnosed with cervical cancer around the…

Source: MSD |

MSD Joins Campaign to ‘Close the Immunization Gap’ and “Stay Polio Free” in Africa

The theme for African Vaccination Week 2016 is “Close the immunization gap. Stay polio free!”

MSD  (www.MSD.com), known as Merck & Co., Inc. in the United States and Canada, has added its voice to the World Health Organization (WHO) campaign to promote the use of vaccines against some of the world’s deadliest diseases, and for countries to strengthen immunization services and systems. World Immunization Week,…

MSD
Source: MSD |

MSD Announces Extension of Access Pricing for Contraceptive Implants Implanon® and Implanon NXT® in Family Planning 2020 Countries

In May 2013, MSD (www.MSD.com), known as Merck within the United States and Canada, and a group of public and private sector partners announced an agreement to expand contraceptive access and options for millions of women in some of the world’s poorest countries. Under the agreement, MSD reduced the cost…